NEW BRUNSWICK: Johnson & Johnson beat first-quarter expectations, as growth in the health care giant’s home market helped counter another revenue hit overseas from a strong dollar.
The health care giant booked a $68 million loss on a one-time charge in the quarter, and revenue grew more than 5 per cent to $24.75 billion, which was better than anticipated.
Adjusted earnings totalled $2.68 per share, topping Wall Street projections for per-share earnings of $2.50, according to a survey by FactSet.
Johnson & Johnson sells prescription drugs and medical devices. It is splitting off its consumer health business, which includes well-known products like BandAids. The company expects to complete the separation this year.
Sales in the US grew nearly 10 per cent to $12.52 billion in the quarter, while international sales climbed nearly 2 per cent.
A strong US dollar can affect sales for companies that do a lot of international business. They have to convert those sales into dollars when they report earnings. The stronger dollar decreases the value of those sales. It also gives foreign products a price edge in the United States.
J&J brings in nearly half of its revenue from outside the United States.
J&J board OK’d a 5 per cent increase in the company’s quarterly dividend. That bumps the amount up to $1.19 per share from $1.13 per share.
The New Brunswick, New Jersey, company on Tuesday also boosted the lower end of its forecasted range for 2023 by a dime. It now expects adjusted earnings of between $10.50 and $10.60 per share.
Analysts expect earnings of $10.51 per share this year.
Shares climbed in early morning trading.
The health care giant booked a $68 million loss on a one-time charge in the quarter, and revenue grew more than 5 per cent to $24.75 billion, which was better than anticipated.
Adjusted earnings totalled $2.68 per share, topping Wall Street projections for per-share earnings of $2.50, according to a survey by FactSet.
Johnson & Johnson sells prescription drugs and medical devices. It is splitting off its consumer health business, which includes well-known products like BandAids. The company expects to complete the separation this year.
Sales in the US grew nearly 10 per cent to $12.52 billion in the quarter, while international sales climbed nearly 2 per cent.
A strong US dollar can affect sales for companies that do a lot of international business. They have to convert those sales into dollars when they report earnings. The stronger dollar decreases the value of those sales. It also gives foreign products a price edge in the United States.
J&J brings in nearly half of its revenue from outside the United States.
J&J board OK’d a 5 per cent increase in the company’s quarterly dividend. That bumps the amount up to $1.19 per share from $1.13 per share.
The New Brunswick, New Jersey, company on Tuesday also boosted the lower end of its forecasted range for 2023 by a dime. It now expects adjusted earnings of between $10.50 and $10.60 per share.
Analysts expect earnings of $10.51 per share this year.
Shares climbed in early morning trading.
For all the latest business News Click Here
Denial of responsibility! TechAI is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
